PRME Prime Medicine, Inc.
Healthcare$2.97+0.68%ClosedMarket Cap: $536.4M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
6.86
P/S
132.98
EV/EBITDA
-3.00
DCF Value
$-0.06
FCF Yield
-29.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-1082.7%
Operating Margin
-5121.8%
Net Margin
-4917.6%
ROE
-188.8%
ROA
-67.3%
ROIC
-77.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $856.0K | -116.8% | $-50.7M | $-49.1M | $— | — |
| Q4 null | $838.0K | 100.0% | $-48.6M | $-46.1M | $— | — |
| FY null | $4.6M | -58.1% | $-208.3M | $-201.1M | $— | — |
| Q3 null | $1.2M | -3491.0% | $-54.0M | $-50.6M | $— | — |
| Q2 null | $1.1M | -67.2% | $-53.4M | $-52.6M | $— | — |
| Q1 null | $1.5M | 100.0% | $-52.4M | $-51.9M | $— | — |
| Q4 null | $2.2M | 100.0% | $-44.2M | $-42.3M | $— | — |
| FY null | $3.0M | 100.0% | $-202.5M | $-195.9M | $— | — |
| Q3 null | $209.0K | 100.0% | $-54.2M | $-52.5M | $— | — |
| Q2 null | $0.00 | NaN% | $-55.7M | $-55.3M | $— | — |
| Q1 null | $591.0K | -122.5% | $-48.3M | $-45.8M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-68.0M | $-65.6M | $-0.67 | — |